Bliss GVS Pharma Limited
Bliss GVS Pharma Limited is an Indian listed company in the Pharmaceuticals & Biotechnology industry (Healthcare sector), traded under NSE: BLISSGVS and BSE: 506197 (ISIN INE416D01022).
It has a market capitalisation of ₹6,633 crore, a last close of ₹627.05 on 2026-10-19, a one-year return of 312.3%.
Valuation: a price-to-earnings ratio of 48.71x, a price-to-book ratio of 5.56x, a dividend yield of 0.2%.
Profitability: return on equity of 11.5%, return on capital employed of 16.9%, an operating margin of 18.6%.
Growth: sales growth of 7.2% a year over three years, net profit growth of 22.1% a year over three years.
Balance sheet and ownership: debt-to-equity of 0.00x, promoter holding of 35.0%.
| Metric | Value |
|---|---|
| Market capitalisation | 6,633 |
| Last close | ₹627.05 |
| P/E (TTM) | 48.71x |
| P/B | 5.56x |
| Dividend yield | 0.2% |
| ROE (FY) | 11.5% |
| ROCE (FY) | 16.9% |
| Operating margin (TTM) | 18.6% |
| Sales growth, 3-year CAGR | 7.2% |
| Profit growth, 3-year CAGR | 22.1% |
| Debt / equity | 0.00x |
| Promoter holding | 35.0% |
| 1-year return | 312.3% |
Loading the live page with the price chart, financial history, shareholding and recent filings. Data is end-of-day and rebuilt nightly; nothing here is investment advice. Financial statements · What each metric means